Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: Clinical validity, reliability and sensitivity to change of the DLQI

British Journal of Dermatology

Volumn 141, Issue 4, 1999, Pages 698-702

  Badia, Xavier ^a   Mascaro J M ^a   Lozano, R ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

Eczema; Psoriasis; Quality of life; Questionnaires; Topical corticosteroids; Validation

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; ECZEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; SPAIN; TOPICAL DRUG ADMINISTRATION; VALIDATION PROCESS;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; ECZEMA; FEASIBILITY STUDIES; FEMALE; GLUCOCORTICOIDS; HEALTH STATUS INDICATORS; HUMANS; MALE; PSORIASIS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 0032717253     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03112.x     Document Type: Article

References (20)

1. 1 Osoba D, Zee B, Pater J et al. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994; 5: 353-64.
2. 2 Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res 1993; 2: 367-8.
3. 3 Patrick DL, Wild DJ, Johnson ES et al. Cross-cultural validation of quality of life measures. In: Orley J, Kuyken W (eds). Quality of Life Assessment: International Perspectives. Heidelberg: Springer-Verlag, 1994: 19-32.
4. 4 Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
5. 5 Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol 1995; 133: 575-8.
6. 6 Newton JN, Mallon E, Klassen A et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997; 4: 563-7.
7. 7 de Tiedra AG, Mercadal J, Badin X et al. Adaptación transcultural al Español del cuestionario Dermatology Life Quality Index (DLQI): el Indice de Calidad de Vida en Dermatologia. Actas Dermo-Sijiliogr 1998; 89: 692-700.
8. 8 Hunt SM, McEwen J. The development of a subjective health indicator. Sociol Health Illness 1980; 2: 231-46.
9. 9 Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 12: 1417-32.
10. 10 Alonso J, Prieto L, Antón JM. The Spanish, Version of the Nottingham Health Prolile: a review of adaptation and instrument characteristics. Qual life Res 1994; 3: 385-93.
11. 11 Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Controlled Clin Trials 1991; 12: 142S-58.
12. 12 Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
13. 13 Cohen J. Statistical Power Analysis for the Behavioural Sciences. New York: Academic Press, 1977.
14. 14 Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132; 236-44.
15. 15 Herd RM, Tidman MJ, Ruta DA, Hunter JA. Measurement of quality of life in alopic dermatitis: correlation and validation of two different methods. Br J Dermatol 1997: 4: 502-7.
16. 16 Harris A. Burge SM, Dykes PJ, Finlay AY. Handicap in Darier's disease and Hailey - Hailey disease. Br J Dermatol 1996; 135: 959-63.
17. 17 Morgan M, McCreedy R, Simpson J, Hay RJ, Dermatology quality of life scales a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202-6.
18. 18 Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined, Version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-40.
19. 19 Sprangers MA. Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials. Cancer Treat Rev 1996; 22(Suppl, A): 55-62.
20. 20 Ware JE, Keller SD. Interpreting general health measures. In: Spilker B (eds). Quality of life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996: 445-60.